Wei Wan

2.6k total citations · 2 hit papers
49 papers, 1.9k citations indexed

About

Wei Wan is a scholar working on Molecular Biology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Wei Wan has authored 49 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 18 papers in Epidemiology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Wei Wan's work include Autophagy in Disease and Therapy (17 papers), Lymphoma Diagnosis and Treatment (11 papers) and Ubiquitin and proteasome pathways (7 papers). Wei Wan is often cited by papers focused on Autophagy in Disease and Therapy (17 papers), Lymphoma Diagnosis and Treatment (11 papers) and Ubiquitin and proteasome pathways (7 papers). Wei Wan collaborates with scholars based in China, Canada and United States. Wei Wan's co-authors include Yinfeng Xu, Wei Liu, Tianhua Zhou, Zhiyuan You, Xin Shou, Rui Huang, Chao Peng, Jennifer Lippincott‐Schwartz, Jiali Qian and Chunmei Chang and has published in prestigious journals such as Nature Communications, The EMBO Journal and Immunity.

In The Last Decade

Wei Wan

43 papers receiving 1.9k citations

Hit Papers

Deacetylation of Nuclear LC3 Drives Autophagy Initiation ... 2015 2026 2018 2022 2015 2022 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Wan China 18 1.0k 957 245 224 205 49 1.9k
Daniel Meley France 9 1.0k 1.0× 1.4k 1.5× 164 0.7× 108 0.5× 346 1.7× 12 2.0k
Chandreyee Mukherjee United States 7 1.4k 1.3× 1.3k 1.3× 185 0.8× 157 0.7× 375 1.8× 8 2.1k
Hwan‐Woo Park South Korea 23 1.1k 1.1× 605 0.6× 210 0.9× 109 0.5× 357 1.7× 57 2.0k
Jaekyoon Shin South Korea 18 1.1k 1.1× 866 0.9× 253 1.0× 62 0.3× 372 1.8× 32 2.1k
Avital Eisenberg‐Lerner Israel 12 985 1.0× 901 0.9× 120 0.5× 78 0.3× 268 1.3× 21 1.7k
Antje S Löffler Germany 9 924 0.9× 1.2k 1.2× 117 0.5× 107 0.5× 281 1.4× 9 1.8k
Sungman Park United States 11 906 0.9× 593 0.6× 208 0.8× 62 0.3× 154 0.8× 19 1.6k
Yinfeng Xu China 15 702 0.7× 775 0.8× 177 0.7× 191 0.9× 175 0.9× 31 1.4k
Zhixun Dou United States 23 1.9k 1.8× 1.1k 1.1× 584 2.4× 190 0.8× 437 2.1× 32 3.2k

Countries citing papers authored by Wei Wan

Since Specialization
Citations

This map shows the geographic impact of Wei Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Wan more than expected).

Fields of papers citing papers by Wei Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Wan. The network helps show where Wei Wan may publish in the future.

Co-authorship network of co-authors of Wei Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Wan. A scholar is included among the top collaborators of Wei Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Wan. Wei Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Liangyong, Zehong Cao, Wei Wan, & Wentao Zhang. (2025). The double-edged sword effect of proactive helping behavior on coworker relationships. Acta Psychologica Sinica. 57(6). 1083–1083.
2.
Wan, Wei, et al.. (2025). MiR-155 overexpression regulates Th1/Th2 balance by inhibiting BACH1 to activate Nrf-2/HO-1 signaling pathway in allergic rhinitis. Archives of Biochemistry and Biophysics. 770. 110454–110454. 1 indexed citations
3.
Xu, Yinfeng & Wei Wan. (2025). The interplay of the cGAS–STING pathway with the lysosome. Trends in Biochemical Sciences. 50(11). 956–959.
4.
Xu, Yinfeng & Wei Wan. (2024). 亚精胺抑制核糖体DNA转录. Chinese Science Bulletin (Chinese Version). 1 indexed citations
5.
Wan, Wei, Lili Xu, Lizhong Guo, et al.. (2024). Transformation of antibiotics to non-toxic and non-bactericidal products by laccases ensure the safety of Stropharia rugosoannulata. Journal of Hazardous Materials. 476. 135099–135099. 4 indexed citations
6.
Xu, Yinfeng & Wei Wan. (2024). Lysosomal control of the cGAS-STING signaling. Trends in Cell Biology. 34(8). 622–625. 7 indexed citations
7.
Xu, Yinfeng, Qian Wang, Jun Wang, et al.. (2024). The cGAS-STING pathway activates transcription factor TFEB to stimulate lysosome biogenesis and pathogen clearance. Immunity. 58(2). 309–325.e6. 23 indexed citations
9.
Fan, Shijie, Wei Wan, Pan Xu, et al.. (2023). An ATG4B inhibitor blocks autophagy and sensitizes Sorafenib inhibition activities in HCC tumor cells. Bioorganic & Medicinal Chemistry. 84. 117262–117262. 13 indexed citations
10.
Wan, Wei, Qian Wang, Jin Li, et al.. (2023). STING directly recruits WIPI2 for autophagosome formation during STING‐induced autophagy. The EMBO Journal. 42(8). e112387–e112387. 46 indexed citations
11.
Xu, Yinfeng & Wei Wan. (2023). Emerging roles of p300/CBP in autophagy and autophagy-related human disorders. Journal of Cell Science. 136(12). 7 indexed citations
12.
Xu, Yinfeng & Wei Wan. (2022). Acetylation in the regulation of autophagy. Autophagy. 19(2). 379–387. 195 indexed citations breakdown →
13.
Shen, Qiuhong, Yin Shi, Jiaqi Liu, et al.. (2020). Acetylation of STX17 (syntaxin 17) controls autophagosome maturation. Autophagy. 17(5). 1157–1169. 89 indexed citations
14.
Xu, Yinfeng & Wei Wan. (2019). TP 53 INP 2 mediates autophagic degradation of ubiquitinated proteins through its ubiquitin‐interacting motif. FEBS Letters. 593(15). 1974–1982. 13 indexed citations
15.
Wan, Wei, Ting He, Feifei Qi, et al.. (2019). Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma. Cancer Gene Therapy. 26(7-8). 248–255. 18 indexed citations
16.
You, Zhiyuan, Ling-Yun Qin, Zhou Gong, et al.. (2019). Requirement for p62 acetylation in the aggregation of ubiquitylated proteins under nutrient stress. Nature Communications. 10(1). 5792–5792. 111 indexed citations
17.
Zhang, Yiting, Minjia Tan, Yongzhen Liu, et al.. (2018). Species-Specific Involvement of Integrin αIIbβ3 in a Monoclonal Antibody CH12 Triggers Off-Target Thrombocytopenia in Cynomolgus Monkeys. Molecular Therapy. 26(6). 1457–1470. 5 indexed citations
18.
Wan, Wei, Zhiyuan You, Li Zhou, et al.. (2018). mTORC1-Regulated and HUWE1-Mediated WIPI2 Degradation Controls Autophagy Flux. Molecular Cell. 72(2). 303–315.e6. 91 indexed citations
19.
Wan, Wei, Zhiyuan You, Yinfeng Xu, et al.. (2017). mTORC1 Phosphorylates Acetyltransferase p300 to Regulate Autophagy and Lipogenesis. Molecular Cell. 68(2). 323–335.e6. 136 indexed citations
20.
Su, Hua, Fei Yang, Qiuting Wang, et al.. (2017). VPS34 Acetylation Controls Its Lipid Kinase Activity and the Initiation of Canonical and Non-canonical Autophagy. Molecular Cell. 67(6). 907–921.e7. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026